Microsatellite Instability and p53 Mutation Associated with Tumor Progression in Dermatofibrosarcoma Protuberans

Tomonari Takahira, Yoshinao Oda, Sadafumi Tamiya, Hidetaka Yamamoto, Kenichi Kawaguchi, Chikashi Kobayashi, Shinya Oda, Yukihide Iwamoto, Masazumi Tsuneyoshi

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Dermatofibrosarcoma protuberans (DFSP) is a dermal and subcutaneous tumor categorized as a tumor of intermediate malignancy, and its progression in some cases to fibrosarcoma is well known. However, molecular analysis of tumor progression has been limited. The present study investigated microsatellite instability (MSI) of 7 microsatellite markers through high-resolution microsatellite analysis in addition to a mutational analysis of the p53 gene in 44 tumors in 36 patients. The patients were divided into 2 groups: 9 patients with a fibrosarcomatous component in the primary or recurrent/metastasized tumor, designated as the DFSP+FS group, and the remaining 27 patients, designated as the DFSP group. Cases in which the percentage of markers with an additional peak among the markers successfully analyzed was more than 30% was considered MSI high (MSI-H); cases in which microsatellites were stable at all of the successfully examined markers were considered microsatellite stable (MSS); and the remaining cases were considered MSI low (MSI-L). MSI-H cases were observed more frequently in the DFSP+FS group (4 of 9 cases) than in the DFSP group (1 of 27 cases) (P = 0.028, Fischer's exact test). The MSI status of recurrent or metastatic tumors in both the DFSP+FS and the DFSP groups was the same as that in the corresponding primary neoplasms. Furthermore, there was no difference in MSI status between an ordinary DFSP area and a fibrosarcomatous area in 7 tumors that exhibited both areas. p53 mutational analysis revealed 10 point mutations, composed of 4 missense mutations and 6 silent mutations, in 6 of 36 cases (16.7%). A missense mutation was more frequently observed in the DFSP+FS group (3 of 4) than in the DFSP group (1 of 4). Among 3 cases of a missense mutation in the DFSP+FS group, 2 had a mutation only in a fibrosarcomatous area and 1 had a mutation only in a metastatic tumor progressing to fibrosarcoma. These results suggest that MSI and p53 mutations are involved in tumor progression of DFSP to fibrosarcoma as early and late events, respectively.

Original languageEnglish
Pages (from-to)240-245
Number of pages6
JournalHuman Pathology
Volume35
Issue number2
DOIs
Publication statusPublished - Jan 1 2004

Fingerprint

Dermatofibrosarcoma
Microsatellite Instability
Mutation
Neoplasms
Microsatellite Repeats
Fibrosarcoma
Missense Mutation
p53 Genes
Point Mutation

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Cite this

Microsatellite Instability and p53 Mutation Associated with Tumor Progression in Dermatofibrosarcoma Protuberans. / Takahira, Tomonari; Oda, Yoshinao; Tamiya, Sadafumi; Yamamoto, Hidetaka; Kawaguchi, Kenichi; Kobayashi, Chikashi; Oda, Shinya; Iwamoto, Yukihide; Tsuneyoshi, Masazumi.

In: Human Pathology, Vol. 35, No. 2, 01.01.2004, p. 240-245.

Research output: Contribution to journalArticle

Takahira, Tomonari ; Oda, Yoshinao ; Tamiya, Sadafumi ; Yamamoto, Hidetaka ; Kawaguchi, Kenichi ; Kobayashi, Chikashi ; Oda, Shinya ; Iwamoto, Yukihide ; Tsuneyoshi, Masazumi. / Microsatellite Instability and p53 Mutation Associated with Tumor Progression in Dermatofibrosarcoma Protuberans. In: Human Pathology. 2004 ; Vol. 35, No. 2. pp. 240-245.
@article{e49d1d23ee254c66b8c7b6297ea723db,
title = "Microsatellite Instability and p53 Mutation Associated with Tumor Progression in Dermatofibrosarcoma Protuberans",
abstract = "Dermatofibrosarcoma protuberans (DFSP) is a dermal and subcutaneous tumor categorized as a tumor of intermediate malignancy, and its progression in some cases to fibrosarcoma is well known. However, molecular analysis of tumor progression has been limited. The present study investigated microsatellite instability (MSI) of 7 microsatellite markers through high-resolution microsatellite analysis in addition to a mutational analysis of the p53 gene in 44 tumors in 36 patients. The patients were divided into 2 groups: 9 patients with a fibrosarcomatous component in the primary or recurrent/metastasized tumor, designated as the DFSP+FS group, and the remaining 27 patients, designated as the DFSP group. Cases in which the percentage of markers with an additional peak among the markers successfully analyzed was more than 30{\%} was considered MSI high (MSI-H); cases in which microsatellites were stable at all of the successfully examined markers were considered microsatellite stable (MSS); and the remaining cases were considered MSI low (MSI-L). MSI-H cases were observed more frequently in the DFSP+FS group (4 of 9 cases) than in the DFSP group (1 of 27 cases) (P = 0.028, Fischer's exact test). The MSI status of recurrent or metastatic tumors in both the DFSP+FS and the DFSP groups was the same as that in the corresponding primary neoplasms. Furthermore, there was no difference in MSI status between an ordinary DFSP area and a fibrosarcomatous area in 7 tumors that exhibited both areas. p53 mutational analysis revealed 10 point mutations, composed of 4 missense mutations and 6 silent mutations, in 6 of 36 cases (16.7{\%}). A missense mutation was more frequently observed in the DFSP+FS group (3 of 4) than in the DFSP group (1 of 4). Among 3 cases of a missense mutation in the DFSP+FS group, 2 had a mutation only in a fibrosarcomatous area and 1 had a mutation only in a metastatic tumor progressing to fibrosarcoma. These results suggest that MSI and p53 mutations are involved in tumor progression of DFSP to fibrosarcoma as early and late events, respectively.",
author = "Tomonari Takahira and Yoshinao Oda and Sadafumi Tamiya and Hidetaka Yamamoto and Kenichi Kawaguchi and Chikashi Kobayashi and Shinya Oda and Yukihide Iwamoto and Masazumi Tsuneyoshi",
year = "2004",
month = "1",
day = "1",
doi = "10.1016/j.humpath.2003.09.016",
language = "English",
volume = "35",
pages = "240--245",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Microsatellite Instability and p53 Mutation Associated with Tumor Progression in Dermatofibrosarcoma Protuberans

AU - Takahira, Tomonari

AU - Oda, Yoshinao

AU - Tamiya, Sadafumi

AU - Yamamoto, Hidetaka

AU - Kawaguchi, Kenichi

AU - Kobayashi, Chikashi

AU - Oda, Shinya

AU - Iwamoto, Yukihide

AU - Tsuneyoshi, Masazumi

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Dermatofibrosarcoma protuberans (DFSP) is a dermal and subcutaneous tumor categorized as a tumor of intermediate malignancy, and its progression in some cases to fibrosarcoma is well known. However, molecular analysis of tumor progression has been limited. The present study investigated microsatellite instability (MSI) of 7 microsatellite markers through high-resolution microsatellite analysis in addition to a mutational analysis of the p53 gene in 44 tumors in 36 patients. The patients were divided into 2 groups: 9 patients with a fibrosarcomatous component in the primary or recurrent/metastasized tumor, designated as the DFSP+FS group, and the remaining 27 patients, designated as the DFSP group. Cases in which the percentage of markers with an additional peak among the markers successfully analyzed was more than 30% was considered MSI high (MSI-H); cases in which microsatellites were stable at all of the successfully examined markers were considered microsatellite stable (MSS); and the remaining cases were considered MSI low (MSI-L). MSI-H cases were observed more frequently in the DFSP+FS group (4 of 9 cases) than in the DFSP group (1 of 27 cases) (P = 0.028, Fischer's exact test). The MSI status of recurrent or metastatic tumors in both the DFSP+FS and the DFSP groups was the same as that in the corresponding primary neoplasms. Furthermore, there was no difference in MSI status between an ordinary DFSP area and a fibrosarcomatous area in 7 tumors that exhibited both areas. p53 mutational analysis revealed 10 point mutations, composed of 4 missense mutations and 6 silent mutations, in 6 of 36 cases (16.7%). A missense mutation was more frequently observed in the DFSP+FS group (3 of 4) than in the DFSP group (1 of 4). Among 3 cases of a missense mutation in the DFSP+FS group, 2 had a mutation only in a fibrosarcomatous area and 1 had a mutation only in a metastatic tumor progressing to fibrosarcoma. These results suggest that MSI and p53 mutations are involved in tumor progression of DFSP to fibrosarcoma as early and late events, respectively.

AB - Dermatofibrosarcoma protuberans (DFSP) is a dermal and subcutaneous tumor categorized as a tumor of intermediate malignancy, and its progression in some cases to fibrosarcoma is well known. However, molecular analysis of tumor progression has been limited. The present study investigated microsatellite instability (MSI) of 7 microsatellite markers through high-resolution microsatellite analysis in addition to a mutational analysis of the p53 gene in 44 tumors in 36 patients. The patients were divided into 2 groups: 9 patients with a fibrosarcomatous component in the primary or recurrent/metastasized tumor, designated as the DFSP+FS group, and the remaining 27 patients, designated as the DFSP group. Cases in which the percentage of markers with an additional peak among the markers successfully analyzed was more than 30% was considered MSI high (MSI-H); cases in which microsatellites were stable at all of the successfully examined markers were considered microsatellite stable (MSS); and the remaining cases were considered MSI low (MSI-L). MSI-H cases were observed more frequently in the DFSP+FS group (4 of 9 cases) than in the DFSP group (1 of 27 cases) (P = 0.028, Fischer's exact test). The MSI status of recurrent or metastatic tumors in both the DFSP+FS and the DFSP groups was the same as that in the corresponding primary neoplasms. Furthermore, there was no difference in MSI status between an ordinary DFSP area and a fibrosarcomatous area in 7 tumors that exhibited both areas. p53 mutational analysis revealed 10 point mutations, composed of 4 missense mutations and 6 silent mutations, in 6 of 36 cases (16.7%). A missense mutation was more frequently observed in the DFSP+FS group (3 of 4) than in the DFSP group (1 of 4). Among 3 cases of a missense mutation in the DFSP+FS group, 2 had a mutation only in a fibrosarcomatous area and 1 had a mutation only in a metastatic tumor progressing to fibrosarcoma. These results suggest that MSI and p53 mutations are involved in tumor progression of DFSP to fibrosarcoma as early and late events, respectively.

UR - http://www.scopus.com/inward/record.url?scp=1242296965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1242296965&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2003.09.016

DO - 10.1016/j.humpath.2003.09.016

M3 - Article

C2 - 14991543

AN - SCOPUS:1242296965

VL - 35

SP - 240

EP - 245

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 2

ER -